Canadian ePrescribing Market Assessment

Evaluation of the Canadian ePrescribing Landscape

‍

Situation

‍

Our client sought to understand the current state of ePrescribing in Canada to inform strategic planning and product development decisions. Specifically, the client wanted clarity on adoption levels, stakeholder perspectives, and remaining gaps across provinces and care settings.

‍

Objective

‍

The objective was to evaluate market momentum, integration complexity, policy influences, and competitive dynamics of the ePrescribing market within Canada.

‍

Our Work

‍

10EQS conducted targeted interviews with pharmacy experts, digital health leaders, and industry stakeholders. Research focused on workflow integration, system interoperability, security benefits, and perceived value across the care continuum.

‍

Project team

• Ex-McKinsey Management Consultant with extensive growth strategy, health care & technology industry experience
• 10EQS Delivery Operations (=PMO) providing quality assurance, process management and expert recruitment
• 5 industry experts

Industry experts (excerpt)

• Director Strategic Marketing & Network Alliance – Healthcare Technology Company (US)
• Executive Director, Pharmacy Operations – Large Health System (US)
• Pharmacy Systems & Support Manager, Lead – Digital Health Technology Company (Canada)
• Executive Vice President – National Digital Health Authority (Canada)

‍

Results

‍

10EQS found that ePrescribing adoption in Canada is expanding, though maturity varies by region. Stakeholders value improvements in prescription security and efficiency, but interoperability gaps and workflow friction limit full impact. These insights enabled our client to sharpen their positioning and prioritize product enhancements aligned with the most pressing market needs.

‍